Results 21 to 30 of about 3,193,785 (231)

An update on the use of indacaterol in patients with COPD

Therapeutic Advances in Respiratory Disease, 2011
Current guidelines for the management of chronic obstructive pulmonary disease (COPD) establish that bronchodilator medications are central to the symptomatic treatment of the disease.
Nadia S. Brienza, Óscar Amor-Carro, David Ramos-Barbón   +2 more
doaj   +1 more source

Intravenous Bronchodilators in Pediatric Critical Asthma: A Systematic Review and Network Meta-Analysis. [PDF]

Pediatr Pulmonol
ABSTRACT Introduction Pediatric critical asthma is one of the most common pediatric illnesses in children admitted to the pediatric ward and pediatric intensive care unit (PICU). Adjunct intravenous (IV) bronchodilators are often used when initial management with systemic corticosteroids and inhaled short‐acting beta agonists (SABA) fail to provide ...
Abu-Sultaneh S, Miller AG, Basnet S, Craven HJ, Dalabih A, Irazuzta JE, Kapuscinski CA, Newth CJL, Said SJ, Whipple EC, Goodfellow LT, White BR, Iyer NP.   +12 more
europepmc   +2 more sources

Calcium and potassium channels are involved in curcumin relaxant effect on tracheal smooth muscles

Pharmaceutical Biology, 2020
Context Curcumin, the active component of Curcuma longa L. (Zingiberaceae), exhibits a wide variety of biological activities including vasodilation and anti-inflammation.
Bahman Emami, Farzaneh Shakeri, Zahra Gholamnezhad, Saeideh Saadat, Marzie Boskabady, Vahab Azmounfar, Hamed Sadatfaraji, Mohammad Hossein Boskabady   +7 more
doaj   +1 more source

COPD and glycopyrronium responsiveness assessment: An appraisal

Lung India, 2023
Clinical Trial Registration: ECR/159/Inst/WB/2013/RR-20 Background: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agonist ...
Parthasarathi Bhattacharyya, Dipanjan Saha, Moumita Chatterjee, Sayoni Sengupta, Debkanya Dey, Rajat Banerjee   +5 more
doaj   +1 more source

Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review [PDF]

Tuberculosis and Respiratory Diseases
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by acute exacerbations that accelerate disease progression, increase hospitalizations, and elevate mortality.
Hyun Woo Lee
doaj   +1 more source

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population

Medicine, 2015
A combination of long-acting anticholinergic agents (LAACs) and long-acting &bgr;2-adrenergic receptor agonist (LABA) is effective in improving lung function in chronic obstructive pulmonary disease (COPD) compared with monotherapy.
M. Tsai, Chung-Yu Chen, Yaw-Bin Huang, Hsiao-Chung Chao, Chih-Jen Yang, Pei-Jin Lin, Y. Tsai   +6 more
semanticscholar   +1 more source

Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil

Jornal Brasileiro de Pneumologia
Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other asthma medications in asthma patients treated by specialists and participating in the SABA use IN Asthma (SABINA) study in Brazil.
Martti Anton Antila, Adelmir Souza-Machado, Marcelo Gervilla Gregório, Álvaro A Cruz, Luciene Angelini, Maarten J H I Beekman, Gilmar Alves Zonzin, Marcelo Fouad Rabahi   +7 more
doaj   +2 more sources

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease

Patient Preference and Adherence, 2023
Luis Fernando Valladales-Restrepo,1– 3 María Camila Oyuela-Gutiérrez,3 Ana Camila Delgado-Araujo,1 Juliana Calvo-Salazar,1 Daniel Osorio-Bustamante,3 Cesar Eduardo Lerma-Barco,3 Jorge Enrique Machado-Alba1 1Grupo de Investigación en Farmacoepidemiología ...
Valladales-Restrepo LF, Oyuela-Gutiérrez MC, Delgado-Araujo AC, Calvo-Salazar J, Osorio-Bustamante D, Lerma-Barco CE, Machado-Alba JE   +6 more
doaj  

Investigation of the assortment of medicines for the treatment of chronic obstructive pulmonary disease in the pharmaceutical market of Ukraine

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2020
The aim of the work – to analyze the assortment of medicines for the treatment of chronic obstructive pulmonary disease (COPD) (bronchodilator therapy (BT). in the modern pharmaceutical market of Ukraine. Materials and Methods.
L. I. Budniak , Ye. Yu. Dynia
doaj   +1 more source

Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III [PDF]

The Korean Journal of Internal Medicine
Background/Aims Despite short-acting β2-agonist (SABA) overuse being associated with poor asthma outcomes, data on SABA use in South Korea is scarce.
Kwang-Ha Yoo, Sang-Ha Kim, Sang-Heon Kim, Ji-Yong Moon, Heung-Woo Park, Yoon-Seok Chang, Maarten J.H.I Beekman   +6 more
doaj   +1 more source